Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.99 USD | -0.99% | -0.11% | +87.60% |
05-09 | Oppenheimer Adjusts Tarsus Pharmaceuticals Price Target to $61 From $59, Maintains Outperform Rating | MT |
05-08 | Transcript : Tarsus Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Bullish | Bullish |
Resistance | 38.37 | 39.22 | 49.62 |
Spread/Res. | -0.99% | -3.14% | -23.44% |
Spread/Supp. | +9.36% | +54.31% | +66.40% |
Support | 34.74 | 24.62 | 22.83 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- TARS Stock
- Charts Tarsus Pharmaceuticals, Inc.